Stocks and Investing Stocks and Investing
Thu, March 9, 2017

Joseph Schwartz Downgraded (ASND) to Hold and Increased Target to $30 on, Mar 9th, 2017


Published on 2024-10-25 20:27:27 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of Leerink Swann, Downgraded "Ascendis Pharma A/S" (ASND) to Hold and Increased Target from $24 to $30 on, Mar 9th, 2017.

Joseph has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $28 on, Thursday, February 9th, 2017

Contributing Sources